Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Recent Progress in the Field of Artificial Organs
Ursoleo, Jacopo D’Andria , Woolley, Brian E. , Curran, Brett F., Doran‐Gallastegi, Ander, Treffalls, John A. , D'Andria Ursoleo, Jacopo , Shah, Aakash

Artificial Organs | August 7, 2025 | Volume: 49 | Issue: 10 | Pages: 1483-1485

10.1111/aor.70002 | PMID 40772601 Get It

Efficient Training Corpus Retrieval for Large Language Model Fine Tuning: A Case Study in Cancer
Das, Avisha , Diala, Chiamaka S , Chen, Guocai , Li, Zhao , Li, Rongbin , Anjum, Omer , Zheng, Wenyun , Li, Rongbin

Studies in Health Technology and Informatics | August 7, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti251039 | PMID 40776057 Get It

The objective is to create an automated knowledge extraction tool for cancer research that builds high-quality academic corpora for LLM fine-tuning while investigating its effectiveness in interleukin-6 and bladder cancer domains. To address the current gap in knowledge retrieval techniques for cancer research data collection, we propose KnowledgePipeline, a novel automated tool that incorporates diverse aspects of academic papers and metadata. Our tool integrates content, co-citations, and co-authorship networks to construct domain-specific academic corpora suitable for fine-tuning LLMs. We leverage two LLMs (GPTJ-6.7B and Galactica30B) trained on domain-specific question-answer pairs from the refined data. The system’s evaluation focuses on both the quality of extracted knowledge and the performance of fine-tuned models in open-ended question-answering tasks. We see that KnowledgePipeline offers a scalable, automated framework for domain-specific knowledge retrieval and fine-tuned applications in cancer research, advancing literature discovery and addressing critical biomedical challenges. It achieved high relevance scores of 68% for IL-6 and 74.5% for bladder cancer, with a fine-tuned Galactica-30B model demonstrating promising capabilities.
Improving Spinal Cord Stimulation Patient Triage: Random Forest Model with Custom Evaluation Functions
Lin, Chen-Ta , Chao, Wei-Lin , Huang, Yu-Li , Liang, Sheng‐Fu , Lin, Chen-Ta , Chao, Wei-Lin , Huang, Yu-Li

Studies in Health Technology and Informatics | August 7, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti251024 | PMID 40776042 Get It

Effective healthcare referral triage poses a significant challenge, especially extracting referral notes on time for scheduling. To offset this issue, this study aims to develop an optimized Random Forest classifier to recreate the referral notes content and identify patients requiring Spinal Cord Stimulation procedures. A performance index was introduced to improve accuracy, while a consistency index was designed to prevent overfitting. The optimized classifier, with the optimal selection at the number of estimates being 5 trees and tree depth being 4, achieved an accuracy of 0.74 with a lower standard deviation, demonstrating its reliability and effectiveness.
A Case Report of Symmetrical Drug‐Related Intertriginous and Flexural Exanthema‐Like Eruption Associated With Borrelial Infection
Espinoza, Elyana, Nguyen, A. , Tran, Tung S, Nguyen, Giang Huong , Tran, Tung S. , Nguyen, Alex V., Tran, Tung S , Nguyen, Giang H , Espinoza, Elyana, Nguyen, Alex V.

Australasian Journal of Dermatology | August 7, 2025 | Volume: 66 | Issue: 7 | Pages: 433-435

10.1111/ajd.14570 | PMID 40772579 Get It

Colonoscopy in obese patients: challenges and emerging solutions
Badurdeen, Dilhana, Acosta, Andres, Huang, Yuting , Acosta, Andres

Current Opinion in Gastroenterology | August 7, 2025 | Volume: 41 | Issue: 5 | Pages: 313-318

10.1097/mog.0000000000001116 | PMID 40772523 Get It

Purpose of review The rising prevalence of obesity, now affecting over 40% of U.S. adults, poses critical implications for colorectal cancer screening, as obesity increases the risk of both colorectal adenomas and cancer. Despite these elevated risks, patients with obesity have lower colonoscopy screening participation and face unique barriers that compromise procedural quality. This review aims to highlight the challenges encountered during colonoscopy in obese patients and examine emerging solutions that may enhance screening effectiveness and patient outcomes. Recent findings Obesity is associated with suboptimal bowel preparation, prolonged cecal intubation times, lower adenoma detection rates, and increased sedation-related complications. These challenges stem from altered gastrointestinal physiology, body habitus, and comorbid conditions. Recent innovations in bowel preparation strategies, sedation protocols, and endoscopic technologies—such as robotic-assisted colonoscopy and artificial intelligence-enhanced visualization—have demonstrated promise in addressing these limitations. Institutional initiatives, including tailored protocols and endoscopy team training, are also contributing to improved outcomes. Summary As obesity rates climb, adapting colonoscopy practices to meet the needs of this population is essential. Incorporating evidence-based strategies and emerging technologies can help overcome procedural barriers, improve detection rates, and reduce disparities in colorectal cancer screening. Continued research and guideline refinement are needed to optimize care delivery for patients with obesity.
Editorial: Detecting and assessing malnutrition: emerging principles and practice
Arends, Jann , Kashani, Kianoush

Current Opinion in Clinical Nutrition & Metabolic Care | August 7, 2025 | Volume: 28 | Issue: 5 | Pages: 365-366

10.1097/mco.0000000000001152 | PMID 40772507 Get It

Short bowel syndrome–associated intestinal failure patient experience: A mixed‐method study leveraging an online patient community
Feldman, Josh , Gower, Megan, Kirby, Michelle, Terreri, Brian , Mundi, Manpreet S. , Feldman, Josh , Mundi, Manpreet S , Chen, Brian , McCue, Maggie

Nutrition in Clinical Practice | August 7, 2025 | Volume: 40 | Issue: 5 | Pages: 1115-1124

10.1002/ncp.70002 | PMID 40772483 Get It

Abstract Background Patients with short bowel syndrome–associated intestinal failure (SBS‐IF) require complex, personalized, and multidisciplinary care; however, there are disparities in access. This study measured the impact of unmet needs and treatment burden among patients and their caregivers. Methods This cross‐sectional, mixed‐method study included US adults self‐reporting SBS‐IF and receiving home parenteral nutrition for ≥6 months and their caregivers. One‐hour interviews informed the development of a 30‐min survey administered to participants from an online health community. Results Among 68 patients, the mean age was 42 years, 79% were female, and 88% were White. Most of the 16 caregivers were female (69%), and younger than 45 years (69%). Of 32 patients (47%) receiving care from an SBS specialist, only 19 (59%) were referred after diagnosis; in 58% of these, referral occurred >6 months after diagnosis. Depression was reported in 44 patients (65%), with 54% not receiving professional mental health care. Financial concerns were common, with 44 patients (65%) unable to work and 40 patients (59%) reporting annual household income of <$50,000. Of 32 patients reporting difficulty paying medical bills, 22 (32%) could not fill prescriptions and 19 (28%) canceled/delayed healthcare provider visits. Social determinant of health challenges were reported by 44 patients (65%). Caregivers' responsibilities impacted their ability to work (50%) and future outlook (63%). Conclusion Patients with SBS‐IF face difficulties accessing specialized healthcare, and are at risk of adverse healthcare outcomes, financial hardships, and poor quality of life. Mental health and work/financial issues were common among both patients and caregivers.
Implementation of the Memory Support System for Individuals with Mild Cognitive Impairment: A Feasibility Survey Study
Brar, Suraj , Santos, Octavio A. , Kassabri, Nicholas , Sweet, Lisa, Knoefel, Frank , Chandler, Melanie , Jaiswal, Atul , Thomas, Neil , Jaana, Mirou

Journal of Dementia and Alzheimer's Disease | August 7, 2025 | Volume: 2 | Issue: 3 | Pages: 26

10.3390/jdad2030026 Get It

Background/Objectives: Mild Cognitive Impairment (MCI), a condition between normal aging and dementia, is characterized by cognitive changes that do not significantly affect instrumental activities of daily living. The Memory Support System (MSS), an evidence-based behavioral intervention developed by the Mayo Clinic, has been shown to aid those living with MCI and their support partners in coping with cognitive challenges. However, the MSS has not been offered clinically within the Canadian context. Therefore, we conducted a study assessing the feasibility of the MSS from the perspectives of individuals living with MCI and their support partners. Methods: Participants from an institutional registry of research participants, patients, and support partners at a memory clinic, as well as members of a local Dementia Society, were approached to complete an online or paper version of a survey assessing feasibility dimensions. Responses were compared between and within groups for differences in mean scores and associations between linked binary choice response questions. Results: A total of 77 responses were received; 39 surveys were completed by participants with MCI, and 38 by support partners. Respondents found the MSS to be acceptable and practical. On average, participants thought it would be more difficult to train in using the MSS than support partners. Both groups expressed interest in the intervention. On average, participants with MCI and support partners preferred virtual MSS training to in-person and indicated more interest in participating in training over six weeks as compared to two weeks. Conclusions: Flexibility in duration and format when offering the MSS are important considerations when offering the intervention as part of a clinical program. Future research should evaluate cost-effectiveness (e.g., financial, staff resources, etc.) of the MSS approach if it were to be institutionalized in the Ontario healthcare system.
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome
Gajjar, Aryan , Raju, Arvind Kumar Venkataramana , Gajjar, Amar , Menon, Mythili, Shah, Syed Asfand Yar , Weinberg, Andrew M., Raju, Arvind Kumar , Gajjar, Amani, Dani, Sourbha S.

Biomedicines | August 7, 2025 | Volume: 13 | Issue: 8 | Pages: 1924

10.3390/biomedicines13081924 | PMID 40868177 Get It

Cardiovascular–Kidney–Metabolic (CKM) syndrome symbolizes a single pathophysiologic entity including obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. These conditions altogether accelerate adverse outcomes when they coexist. Recent evidence has shown that the function of glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium–glucose cotransporter-2 inhibitors (SGLT2i) alleviate stress on multiple organs. SGLT2i has been demonstrated to benefit heart failure, hemodynamic regulation, and renal protection while GLP-1RA on the other hand has been shown to demonstrate a strong impact on glycemic management, weight loss, and atherosclerotic cardiovascular disease. This review will aim to understand and evaluate the mechanistic rationalization, clinical evidence, and the potential therapeutic treatment of SGLT2 inhibitors and GLP-1 receptor agonists to treat individuals who have CKM syndrome. This analysis also assesses whether combination therapy can be a synergistic approach that may benefit patients but is still underutilized because of the lack of clear guidelines, the associated costs, and disparities in accessibility. Therefore, in this review, we will be discussing the combination therapy’s additive and synergistic effects, current recommendations and clinical evidence, and mechanistic insights of these GLT2 inhibitors and GLP-1 receptor agonists in CKM syndrome patients. Overall, early and combination usage of GLP-1RA and SGLT2i may be essential to demonstrating a significant shift in modern cardiometabolic therapy toward patient-centered care.
A Language Vision Model Approach for Automated Tumor Contouring in Radiation Oncology
Luo, Yi , Hooshangnejad, Hamed , Feng, Xue , Huang, Gaofeng , Chen, X. R. , Zhang, Rui , Chen, Quan , Ngwa, Wil, Ding, Kai , Chen, Quan , Chen, Xiaojian , Feng, Xue , Ding, Kai , Ngwa, Wilfred

Bioengineering | August 7, 2025 | Volume: 12 | Issue: 8 | Pages: 835

10.3390/bioengineering12080835 | PMID 40868348 Get It

Background: Lung cancer ranks as the leading cause of cancer-related mortality worldwide. The complexity of tumor delineation, crucial for radiation therapy, requires expertise often unavailable in resource-limited settings. Artificial Intelligence (AI), particularly with advancements in deep learning (DL) and natural language processing (NLP), offers potential solutions yet is challenged by high false positive rates. Purpose: The Oncology Contouring Copilot (OCC) system is developed to leverage oncologist expertise for precise tumor contouring using textual descriptions, aiming to increase the efficiency of oncological workflows by combining the strengths of AI with human oversight. Methods: Our OCC system initially identifies nodule candidates from CT scans. Employing Language Vision Models (LVMs) like GPT-4V, OCC then effectively reduces false positives with clinical descriptive texts, merging textual and visual data to automate tumor delineation, designed to elevate the quality of oncology care by incorporating knowledge from experienced domain experts. Results: The deployment of the OCC system resulted in a 35.0% reduction in the false discovery rate, a 72.4% decrease in false positives per scan, and an F1-score of 0.652 across our dataset for unbiased evaluation. Conclusions: OCC represents a significant advance in oncology care, particularly through the use of the latest LVMs, improving contouring results by (1) streamlining oncology treatment workflows by optimizing tumor delineation and reducing manual processes; (2) offering a scalable and intuitive framework to reduce false positives in radiotherapy planning using LVMs; (3) introducing novel medical language vision prompt techniques to minimize LVM hallucinations with ablation study; and (4) conducting a comparative analysis of LVMs, highlighting their potential in addressing medical language vision challenges.